Skip to Content

Cellectis

CLLS

Buy $CLLS at eToro
Rank 4636
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 8 RUE DE LA CROIX JARRY, PARIS, LLE-DE-FRANCE, FR

Cellectis - Key figures

Market cap 185.68 Million
Revenue 29.56 Million
Profit 34.18 Million
P/E Ratio No information
P/s Ratio 6.28
Buy $CLLS at eToro

Cellectis - Description

Cellectis SA, a clinical-stage biotechnology company, develops immuno-oncology products based on gene-edited T cells that express chimeric antigen receptors to attack and eradicate cancer cells.

The company is headquartered in Paris, France.